Jump to ContentJump to Main Navigation
Show Summary Details

Advances in Cell Biology

The Journal of Foundation for Cell Biology and Molecular Biology

4 Issues per year

Open Access
See all formats and pricing

Insulin Receptor and its Relationship with Different Forms of Insulin Resistance

Aleksandra Rojek
  • Corresponding author
  • PhD in Molecular Biology Home address: 92/51 M.C. Sklodowskiej-Curie Street, 85-733 Bydgoszcz
  • Email:
/ Marek Niedziela
  • Poznan University of Medical Sciences, 2nd Chair of Pediatrics, Department of Pediatric Endocrinology and Diabetology, Molecular Endocrinology Laboratory 27/33 Szpitalna Street 60-572 Poznan, Poland
Published Online: 2014-10-15 | DOI: https://doi.org/10.2478/v10052-010-0004-8


Insulin plays an important role in maintaining the whole organism’s homeostasis. The presence of insulin receptors in all vertebrates and invertebrates cells reflects the diversity of regulatory processes in which this hormone is involved. Furthermore, many different factors may influence the level of insulin receptor expression. These factors include e.g. the sole insulin or stage of development. Mutations in the receptor may lead to the development of insulin resistance. These mutations differ in the level of severity and are frequently associated with diabetes mellitus, hypertension, cardiovascular disorders, heart failure, metabolic syndrome and infertility in women. More than 50 mutations in insulin receptor gene have already been characterized. These mutations are associated with rare forms of insulin resistance like leprechaunism, insulin resistance type A or Rabson-Mendenhall syndrome. Molecular analysis of insulin receptor gene may lead to a better understanding of molecular mechanisms underlying various types of insulin resistance and help to develop more efficient treatment.

Keywords : insulin receptor; INSR gene; alternative splicing; insulin receptor isoforms; hybrid receptors; insulin resistance


  • [1] ADJEI AA, HIDALGO M. Intracellular signal transduction pathway proteins as targets for cancer therapy. J Clin Oncol 2005; 23: 5386-5403. [Crossref]

  • [2] AL-GAZALI LI, KHALIL M, DEVADAS K. A syndrome of insulin resistance resembling leprechaunism in five sibs of consanguineous parents. J Med Genet 1993; 30: 470-475.

  • [3] ARAKI E, SHIMADA F, UZAWA H, MORI M, EBINA Y. Characterization of the promoter region of the human insulin receptor gene. Evidence for promoter activity. J Biol Chem 1987; 262(33): 16186-16191.

  • [4] ARAKI E, MURAKAMI T, SHIROTANI T, KANAI F, SHINOHARA Y, SHIMADA F, MORI M, SHICHIRI M, EBINA Y. A cluster of four Sp1 binding sites required for efficient expression of the human insulin receptor gene. J Biol Chem 1991; 266: 3944-3948.

  • [5] ARIDOR M, BALCH WE. Integration of endoplasmic reticulum signaling in health and disease. Nat Med 1999; 5: 745-751. [Crossref] [PubMed]

  • [6] ARIOGLU E, ANDEWELT A, DIABO C, BELL M, TAYLOR SI, GORDEN P. Clinical course of the syndrome of autoantibodies to the insulin receptor (type B insulin resistance): a 28-year perspective. Medicine (Baltimore) 2002; 81: 87-100. [Crossref]

  • [7] BACKELJAUW PF, ALVES C, EIDSON M, CLEVELAND W, UNDERWOOD LE, DAVENPORT ML. Effect of intravenous insulin-like growth factor I in two patients with leprechaunism. Pediatr Res 1994; 36: 749-754. [Crossref]

  • [8] BALVAY L, LIBRI D, FISZMAN MY. Pre-mRNA secondary structure and the regulation of splicing. BioEssays 1993; 15: 165-169. [Crossref]

  • [9] BARBETTI F, GEJMAN PV, TAYLOR SI, RABEN N, CAMA A, BONORA E, PIZZO P, MOGHETTI P, MUGGEO M, ROTH J. Detection of mutations in insulin receptor gene by denaturing gradient gel electrophoresis. Diabetes 1992; 41: 408-415. [Crossref]

  • [10] BENYOUCEF S, SURINYA KH, HADASCHIK D, SIDDLE K. Characterization of insulin/IGF hybrid receptors: contributions of the insulin receptor L2 and Fn1 domains and the alternatively spliced exon 11 sequence to ligand binding and receptor activation. Biochem J 2007; 403: 603-613.

  • [11] BLACK DL. Mechanisms of alternative pre-messanger RNA splicing. Annu Rev Biochem 2003; 72: 291-336. [Crossref]

  • [12] BRUNETTI A, MADDUX BA, WONG KY, GOLDFINE ID. Muscle differentiation is associated with increased insulin receptor biosynthesis and messenger RNA levels. J Clin Invest 1989; 83: 192-198. [Crossref]

  • [13] BRUNETTI A, GOLDFINE ID. Differential effects of fibroblast growth factor on insulin receptor and muscle specific protein gene expression in BC3H-1 myocytes. Mol Endocrinol 1990; 4: 880-885.

  • [14] [14] BRUNETTI A, FOTI D, GOLDFINE ID. Identification of unique nuclear regulatory proteins for the insulin receptor gene which appear during myocyte and adipocyte differentiation. J Clin Invest 1993; 92: 1288-1295. [Crossref]

  • [15] BRUNETTI A, MANFIOLETTI G, CHIEFARI E, GOLDFINE ID, FOTI D. Transcriptional regulation of human insulin receptor gene by the high-mobility group protein HMGI-Y. FASEB J 2001; 15: 492-500. [Crossref]

  • [16] BRUNING PF, BONFRER JM, VAN NOORD PA, et al. Insulin resistance and breast-cancer risk. Int J Cancer 1992; 52: 511-516. [Crossref]

  • [17] BUCHNER J. Hsp90 & Co. - a holding for holding. Trends Biochem Sci 1999; 24: 136-141. [Crossref]

  • [18] BURATTI E, BARALLE M, BARALLE FE. Defective splicing, disease and therapy: searching for master checkpoints in exon definition. Nucleic Acids Res 2006; 34: 3494-3510. [Crossref]

  • [19] BURD CG, DREYFUSS G. Conserved structures and diversity of functions of RNA-binding proteins. EMBO J 1994; 13: 1197-1204.

  • [20] BUSTIN M, REEVES R. High-mobility-group proteins: architectural components that facilitates chromatin function. Prog Nucleic Acids Res 1996; 54: 35-100. [Crossref]

  • [21] CÀCERES JF, STAMM S, Helfman DM, KRAINER AR. Regulation of alternative splicing in vivo by overexpression of antagonistic splicing factors. Science 1994; 265: 1706-1709.

  • [22] COCHRAN E, YOUNG JR, SEBRING N, DE PAOLLI A. Efficacy of recombinant methionyl human leptin therapy for the extreme insulin resistance of the Rabson-Mendenhall Syndrome. J Clin Endocrinol Metab 2004; 89(4): 1548-1554. [Crossref]

  • [23] DE MEYTS P, ROTH J, NEVILLE DM JR, GAVIN JR III, LESNIAK MA. Insulin interactions with its receptors: experimental evidence for negative cooperativity. Biochem Biophys Res Commun 1973; 55(1): 154-161. [Crossref]

  • [24] DE MEYTS P, BAINCO AR, ROTH J. Site-site interactions among insulin receptors. Characterization of the negative cooperativity. J Biol Chem 1976; 251(7): 1877-1888.

  • [25] DE MEYTS P, WHITTAKER J. Structural biology of insulin and IGF1 receptors: implications for drug design. Nat Rev Drug Discov 2002; 1: 769-783.

  • [26] DONOHUE WL, UCHIDA I. Leprechaunism: an euphemism for a rare familial disorder. J Pediatr 1954; 45: 505-519. [Crossref]

  • [27] EBINA Y, ELLIS L, YARNAGIN K, EDERY M, GRAF L, CLAUSER E, OU JH, MASIARZ F, KAN YW, GOLDFINE ID, et al. The human insulin receptor cDNA: the structural basis for hormone-activated transmembrane signalling. Cell 1975; 40: 747-758.

  • [28] EHRMANN DA, BARNES RB, ROSENFIELD RL. Polycystic ovary syndrome as a form of functional ovarian hyperandrogenism due to dysregulation of androgen secretion. Endocr Rev 1995; 16: 322-353. [Crossref]

  • [29] EHRMANN DA, CAVAGHAN MK, IMPERIAL J, STURIS J, ROSENFIELD RL, POLONSKY KS. Effects of metformin on insulin secretion, insulin action, and ovarian steroidogenesis in women with polycystic ovary syndrome. J Clin Endocrinol Metab 1997; 82: 524-530.

  • [30] EHRMANN DA, SCHNEIDER DJ, SOBEL BE, CAVAGHAN MK, IMPERIAL J, ROSENFIELD RL, POLONSKY KS. Troglitazone improves defects in insulin action, insulin secretion, ovarian steroidogenesis, and fibrinolysis in women with polycystic ovary syndrome. J Clin Endocrinol Metab 1997; 82: 2108-2116.

  • [31] ELLGAARD L, HELENIUS A. ER quality control: towards an understanding at the molecular level. Curr Opin Cell Biol 2001; 13: 431-437. [Crossref]

  • [32] EPERON LP, GRAHAM IR, GRIFFITHS AD, EPERON IC. Effects of RNA secondary structure on alternative splicing of pre-mRNA: is folding limited to a region behind the transcribing RNA polymerase? Cell 1988; 54(3): 393-401. [Crossref]

  • [33] FAIVRE S, DJELLOUL S, RAYMOND E. New paradigms in anticancer therapy: Targeting multiple signaling pathways with kinase inhibitors. Semin Oncol 2006; 33: 407-420. [Crossref] [PubMed]

  • [34] FEDERICI M, PORZIO O, ZUCARO L, et al. Distribution of insulin/insulin-like growth factor-I hybrid receptors in human tissues. Mol Cell Endocrinol 1997; 129: 121-126. [Crossref]

  • [35] FEDERICI M, LAURO D, D’ADAMO M, et al. Expression of insulin/IGF-I hybrid receptors is increased in skeletal muscle of patients with chronic primary hyperinsulinemia. Diabetes 1998; 47: 87-92. [Crossref]

  • [36] FEDERICI M, PORZIO O, LAURO D, et al. Increased abundance of insulin/insulin-like growth factor-I hybrid receptors in skeletal muscle of obese subjects is correlated with in vivo insulin sensitivity. J Clin Endocrinol Metab 1998; 83: 2911-2915.

  • [37] FOTI D, JULIANO R, CHIEFARI E, BRUNETTI A. A nucleoprotein complex containing Sp1, C/EBPβ, and HMGI-Y controls human insulin receptor gene transcription. Moll Cell Biol 2003; 23(8): 2720-2732. [Crossref]

  • [38] FRASCA F, PANDINI G, SCIACCA L, et al. Insulin receptor isoform A, a newly recognized, high-affinity insulin-like growth factor II receptor in fetal and cancer cells. Mol Cell Biol 1999; 19: 3278-3288.

  • [39] FREYCHET P, ROTH J, NEVILLE Jr DM. Insulin receptors in the liver: specific binding of [125I]insulin to the plasma membrane and its relation to insulin bioactivity. Proc Natl Acad Sci USA 1971; 68(8): 1833-1837.

  • [40] GARG A, AGARWAL AK. Lipodystrophies: Disorders of adipose tissue biology. Biochem Biophys Acta 2009; 91(6): 507-513.

  • [41] GHAZEERI G, KUTTEH WH, BRYER-ASH M, HAAS D, KE RW. Effect of rosiglitazone on spontaneous and clomiphene citrateinduced ovulation in women with polycystic ovary syndrome. Fertil Steril 2003; 79: 562-566. [Crossref]

  • [42] GIDDINGS SJ, CARNAGHI LR. Insulin receptor gene expression during development: developmental regulation of insulin receptor mRNA abundance in embryonic rat liver and yolk sac, developmental regulation of insulin gene splicing, and comparison to abundance of insulin-like growth factor 1 receptor mRNA. Mol Endocrinol 1992; 6(10): 1665-1672.

  • [43] GIOVANNONE B, SCALDAFERRI ML, FEDERICI M. et al. Insulin receptor substrate (IRS) transduction system: distinct and overlapping signaling potential. Diabetes Metab Res Rev 2000; 16: 434-441. [Crossref]

  • [44] GOLLOB JA, SCOTT W, CARTER C, KELLEY SL. Role of Raf kinase in cancer: Therapeutic potential of targeting the Raf/Mek/Eerk signal transduction pathway. Sem Oncol 2006; 33: 392-406. [Crossref]

  • [45] GRAVELEY BR. Mutually exclusive splicing of the insect Dscam pre-mRNA directed by competing intronic RNA secondary structures. Cell 2005; 123: 65-73. [Crossref]

  • [46] GUAN KL. The mitogen activated protein kinase signal transduction pathway: from the cell surface to the nucleus. Cell Signal 1994; 6: 581-589. [Crossref]

  • [47] HAAS DA, CARR BR, ATTIA GR. Effects of metformin on body mass index, menstrual cyclicity, and ovulation induction in women with polycystic ovary syndrome. Fertil Steril 2003; 79: 469-481. [Crossref]

  • [48] HANSEN T, BJØRBAEK C, VESTERGAARD H, GRØNSKOV K. Expression of insulin receptor spliced variants and their functional correlates in muscle from patients with non-insulin-dependent diabetes mellitus. J Clin Endocrinol Metab 1993; 77(6): 1500-1505.

  • [49] HARDAWAY CA, GIBBS NF. What Syndrome Is This? Pediatr Dermatol 2002; 19(3): 267-270.

  • [50] HARRIS AM, HALL B, KRISS VM, FOWLKES JL, KIESSLING SG. Rabson-Mendenhall syndrome: medullary sponge kidney, a new component. Pediatr Nephrol 2007; 22: 2141-2144. [Crossref]

  • [51] HEGELE RA, ANDERSON CM, WANG J, JONES DC, CAO H. Association between nuclear lamin A/C R482Q mutation and partial lipodystrophy with hyperinsulinemia, dyslipidemia, hypertension, and diabetes. Genome Res 2000; 10(5): 652-658.

  • [52] HELENIUS A, TROMBETTA ES, HEBERT DN, SIMONS JF. Calnexin, calreticulin and the folding of glycoproteins. Trends Cell Biol 1997; 7: 193-200.

  • [53] HILLER M, ZHANG Z, BACKOFEN R, STAMM S. Pre-mRNA secondary structures influence exon recognition. PLoS Genet 2007; 3: c204. [Crossref]

  • [54] HOEY T, WEINZIERL RO, GILL G, CHEN JL, DYNLACHT BD, TJIAN R. Molecular cloning and functional analysis of Drosophila TAF110 reveal properties expected of coactivators. Cell 1993; 72(2): 247-260. [Crossref]

  • [55] HSU IR, KIM SP, KABIR M, BERGMAN RN. Metabolic syndrome, hyperinsulinemia, and cancer. Am J Clin Nutr 2007; 86(3): Suppl. 867-871.

  • [56] HU FB, MANSON JE, LIU S, et al. Prospective study of adult onset diabetes mellitus (type 2) and risk of colorectal cancer in women. J Natl Cancer Inst 1999; 91: 542-547. [Crossref]

  • [57] Insulin receptor no. 147670: defect in insulin receptor, with insulin resistant diabetes mellitus, acanthosis nigricans, and Type A. Online Mendelian Inheritance in Man (OMIM). Johns Hopkins University. Victor A. McKusick. 6/2/1986. http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi? id=147670.

  • [58] ISHII S, XU Y-H, STRATTON RH, ROE BA, MERLINO GT, PASTAN I. Characterization and sequence of the promoter region of the human epidermal growth factor receptor gene. PNAS 1985; 82(15): 4920-4924. [Crossref]

  • [59] JOSPE N, ZHU J, LIU R, LIVINGSTON JN, FURLANETTO RW. Deletion of 3 basepairs resulting in the loss of lysine-121 in the insulin receptor alpha-subunit in a patient with leprechaunism: binding, phosphorylation, and biological activity. J Clin Endocrinol Metab 1994; 79: 1294-1302.

  • [60] KADOWAKI T, BEVINS CL, CAMA A, OJAMAA K, MARCUS-SAMUELS B, KADOWAKI H, BEITZ L, MCKEON C, TAYLOR SI. Two mutant alleles of the insulin receptor gene in a patient with extreme insulin resistance. Science 1988; 240: 787-790.

  • [61] KADOWAKI T, KADOWAKI H, RECHLER MM, SERRANO-RIOS M, ROTH J, GORDEN P, et al. Five mutant alleles of the insulin receptor gene in patients with genetic forms of insulin resistance. J Clin Invest 1990; 86: 254-264. [Crossref]

  • [62] KAHN CR, FLIER JS, BAR RS, ARCHER JA, GORDEN P, MARTIN MM, ROTH J. The syndromes of insulin resistance and acanthosis nigricans. Insulin-receptor disorders in man. N Engl J Med 1976; 294: 739-745.

  • [63] KALLO A, LAKATOS I, SZIJARTO L. Leprechaunism (Donohue’s syndrome). J Pediatr 1965; 66: 372-379. [Crossref]

  • [64] KARIN M, HASLINGER A, HOLTGREVE H, RICHARDS RI, KRAUTER P, WESTPHAL HM, BEATO M. Characterization of DNA sequences through which cadmium and glucocorticoid hormones induce human metallothionein-IIA gene. Nature 1984; 308(5959): 513-519.

  • [65] KELLERER M, SESTI G, SEFFER B, OBERMAIER-KUSSER DE, PONGRATZ L, MOSTHAF L, HARING HU. Altered pattern of insulin receptor isotypes in skeletal muscle membranes of type 2 (non-insulin-dependent) diabetic subjects. Diabetologia 1993; 36: 628-632. [Crossref]

  • [66] KIM HS, LEE JK, TSAI SY. E1a activation of insulin receptor gene expression is mediated by Sp1- binding sites. Mol Endocrinol 1994; 9: 178-186.

  • [67] KIM SH, MOORES JC, DAVID D, RESPESS JG, JOLLY DJ, FRIEDMANN T. The organization of the human HPRT gene. Nucleic Acids Res 1986; 14(7): 3130-3118.

  • [68] KIRBY E, BEALS D. Fibroepithelial papillomatosis (“skin tags”) in Rabson-Mendenhall syndrome. J Pediatr Surg 2008; 43: E21-E26. [Crossref]

  • [69] KOLCH W. Meaningful relationships: The regulation of the Ras/Raf/Mek/Erk pathway by protein interaction. Biochem J 2000; 351: 289-305. [Crossref]

  • [70] KOSAKI A, WEBSTER NJ. Effect of dexamethasone on the alternative splicing of the insulin receptor mRNA and insulin action in HepG2 hepatoma cells. J Biol Chem 1993; 268(29): 21990-21996.

  • [71] KOSAKI A, PILLAY TS, XU L, WEBSTER NJG. The B isoform of the insulin receptor signals more efficiently than the A isoform in HepG2 cells. J Biol Chem 1995; 35(1): 20816-20823. [Crossref]

  • [72] KOSAKI A, NELSON J, WEBSTER NJG. Identification of intron and exon sequences involved in alternative splicing of insulin receptor pre-mRNA. J Biol Chem 1998; 273: 10331-10337. [Crossref]

  • [73] KRISTENSEN C, WIBERG FC, SCHAFFER L, ANDERSEN AS. Expression and characterization of a 70-kDa fragment of the insulin receptor that binds insulin. J Biol Chem 1998; 273: 17780-17786.

  • [74] KUO H-C, NASIM FH, GRABOWSKI PJ. Control of alternative splicing by the differential binding of U1 small nuclear ribonucleoprotein particle. Science 1991; 252: 1045-1050. [Crossref]

  • [75] LANGLOIS WJ, SASAOKA T, YIP CC, OLEFSKY JM. Functional characterization of hybrid receptors composed of a truncated insulin receptor and wild type insulin-like growth factor 1 or insulin receptor. Endocrinology 1995; 136: 1978-1986.

  • [76] LEE JK, TAM JW, TSAI MJ, TSAI SY. Identification of cis- and trans-acting factors regulating the expression of the human insulin receptor gene. J Biol Chem 1992; 267(7): 4638-4645.

  • [77] LEITNER JW, KLINE T, CAREL K, et al. Hyperinsulinemia potentiates activation of p21Ras by growth factors. Endocrinology 1997; 138: 2211-2214.

  • [78] Leprechaunism no. 246200: defect in insulin receptor, with Donohue syndrome. Online Mendelian Inheritance in Man (OMIM). Johns Hopkins University. Victor A. McKusick: 6/3/1986. http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=246200.

  • [79] LIU K, STAMLER J, MOSS D, et al. Dietary cholesterol, fat, and fibre, and colon-cancer mortality. An analysis of international data. Lancet 1979; 2: 782-785. [Crossref]

  • [80] LONGO N, WANG Y, SMITH SA, LANGLEY SD, DIMEGLIO LA, GIANELLA-NETO D. Genotype-phenotype correlation in inherited severe insulin resistance. Hum Mol Genet 2002; 11(12): 1465-1475. [Crossref]

  • [81] MAMULA PW, MC DONALD AR, BRUNETTI A, OKABAYASHI Y, WONG KY, MADDUX BA, LOGSDON C, GOLDFINE ID. Regulating insulin-receptor-gene expression by differentiation and hormones. Diabetes Care 1990; 13(3): 288-301. [Crossref]

  • [82] MARINO-BUSLJE C, MARTIN-MARTINEZ M, MIZUGUCHI K, SIDDLE K, BLUNDELL TL. The insulin receptor: from protein sequence to structure. Biochem Soc Trans 1999; 27: 715-726.

  • [83] MC CLAIN DA. Different ligand affinities of the two insulin receptor splice variants are reflected in parallel changes in sensitivity for insulin action. Mol Endocrinol 1991; 5: 734-739. [Crossref]

  • [84] MC DONALD AR, MADDUX BA, OKABAYASHI Y, WONG KY, HAWLEY DM, LOGSDON CD, GOLDFINE ID. Regulation of insulin-receptor mRNA levels by glucocorticoids. Diabetes 1987; 36(6):779-781. [Crossref]

  • [85] MC KEON C, ACCILI D, CHEN H, PHAM T, WALKER GE. A conserved region in the first intron of the insulin receptor gene binds nuclear proteins during adipocyte differentiation. Biochem Biophys Res Commun 1997; 240: 701-706.

  • [86] MC KEOWN M. Alternative mRNA splicing. Annu Rev Cell Biol 1992; 8: 133-155.

  • [87] MC KERN NM, LAWRENCE MC, STRELTSOV VA, LOU MZ, ADAMS TE, LOVRECZ GO, ELLEMAN TC, RICHARDS KM, BENTLEY JD, PILLING PA, et al. Structure of the insulin receptor ectodomain reveals a folded-over conformation. Nature 2006; 443: 218-221.

  • [88] MILOS PM, ZARET KS. A ubiquitous factor is required for C/EBP-related proteins to form stable transcription complexes on an albumin promoter segment in vitro. Genes Dev 1992; 6: 991-1004. [Crossref]

  • [89] MINK PJ, SHAHAR E, ROSAMOND WD, et al. Serum insulin and glucose levels and breast cancer incidence: the Atherosclerosis Risk in Communities study. Am J Epidemiol 2002; 156: 349-352. [Crossref]

  • [90] MOGHETTI P, CASTELLO R, NEGRI C, TOSI F, PERRONE F, CAPUTO M, ZANOLIN E, MUGGEO M. Metformin effects on clinical features, endocrine and metabolic profiles, and insulin sensitivity in polycystic ovary syndrome: a randomized, double-blind, placebo controlled 6-month trial, followed by open, long-term clinical evaluation. J Clin Endocrinol Metab 2000; 85: 139-146

  • [91] MOLLER DE, YOKOTA A, CARO JF, FLIER JS. Tissue-specific expression of two alternatively spliced insulin receptor mRNAs in man. Mol Endocrinol 1989; 3: 1263-1269. [Crossref]

  • [92] MOLLER DE, YOKOTA A, PAZIANOS A, FLIER JS. A missense mutation in one allele of the tyrosine kinase domain of the insulin receptor gene is associated with dominantly inherited insulin resistance. (Abstract) Clin Res 1990; 38: 435A.

  • [93] MOLLER DE, COHEN O, YAMAGUCHI Y, ASSIZ R, GRIGORESCU F, EBERLE A, MORROW LA, MOSES AC, FLIER JS. Prevalence of mutations in the insulin receptor gene in subjects with features of the type A syndrome of insulin resistance. Diabetes 1994; 43: 247-255. [Crossref]

  • [94] MOSTHAF L, GRAKO D, DULL TJ, COUSSENS L, ULLRICH A, MC CLAIN DA. Functionally distinct insulin receptors generated by tissue-specific alternative splicing. EMBO J 1990; 9: 2409-2413.

  • [95] MOSTHAF L, VOGT H, HARING U, ULLRICH A. Altered expression of insulin receptor types A and B in the skeletal muscle of non-insulin-dependent diabetes mellitus patients. Proc Natl Acad Sci USA 1991; 88: 4728-4730. [Crossref]

  • [96] MURPHY TK, CALLE EE, RODRIGUEZ C, et al. Body mass index and colon cancer mortality in a large prospective study. Am J Epidemiol 2000; 152: 847-854. [Crossref]

  • [97] MUSSO C, COCHRAN E, MORAN SA, SKARULIS MC, ORAL EA, TAYLOR SI, GORDEN P. Clinical course of genetic diseases of the insulin receptor (type A and Rabson-Mendenhall syndromes): a 30 years prospective. Medicine (Baltimore) 2004; 83: 209-222.

  • [98] MUSSO C, COCHRAN E, JAVOR E, YOUNG J, DEPAOLI AM, GORDEN P. The long-term effect of recombinant methionyl human leptin therapy on hyperandrogenism and menstrual function in female and pituitary function in male and female hypoleptinemic lipodystrophic patients. Metabolism 2005; 54: 255-263. [Crossref]

  • [99] MUSSO C, SHAWKER T, COCHRAN E, JAVOR ED, YOUNG J, GORDEN P. Clinical evidence that hyperinsulinaemia independent of gonadotropins stimulates ovarian growth. Clin Endocrinol 2005; 63: 73-78. [Crossref]

  • [100] MÜLLER-WIELAND D, VAN DER VORM ER, STREICHER R, KRONE W, SEEMANOVA E, DREYER M, RÜDIGER HW, ROSIPAL SR, MAASSEN JA. An in-frame insertion in exon 3 and a nonsense mutation in exon 2 of the insulin receptor gene associated with severe insulin resistance in a patient with Rabson-Mendenhall syndrome Diabetologia 1993; 36: 1168-1174. [Crossref]

  • [101] NELSON KK, GREEN MR. Mechanism for cryptic splice site activation during pre-mRNA splicing. Proc Natl Acad USA 1990; 87: 6253-6525. [Crossref]

  • [102] NELSON VL, QIN KN, ROSENFIELD RL, WOOD JR, PENNING TM, LEGRO RS, STRAUSS JF, MC ALLISTER JM. The biochemical basis for increased testosterone production in theca cells propagated from patients with polycystic ovary syndrome. J Clin Endocrinol Metab 2001; 86: 5925-5933. [Crossref]

  • [103] NESTLER JE. Role of hyperinsulinemia in the pathogenesis of the polycystic ovary syndrome, and its clinical implications. Semin Reprod Endocrinol 1997; 15: 111-122. [Crossref]

  • [104] NORGREN S, ZIERATH J, WEDELL A, WALLEBERG-HENRIKSSON H, LUTHMAN H. Regulation of human insulin receptor RNA splicing in vivo. Proc Natl Acad Sci USA 1994; 91: 1465-1469. [Crossref]

  • [105] NORGREN S, LI LS, LUTHMAN H. Regulation of human insulin receptor RNA splicing in HepG2 cells: effects of glucocorticoid and low glucose concentration. Biochem Biophys Res Commun 1994; 199: 277-284. [Crossref]

  • [106] NORGREN S, ZIERATH J, GALUSKA D, WALLBERG-HENRIKSSON H, LUTHMAN H. Differences in the ratio of RNA encoding two isoforms of the insulin receptor between control and NIDDM patients. The RNA variant without Exon 11 predominates in both groups. Diabetes 1993; 42: 675-681.

  • [107] OLSON TS, BAMBERGER MJ, LANE MD. Post-translational changes in tertiary and quaternary structure of the insulin proreceptor: correlation with acquisition of function. J Biol Chem 1998; 263: 7342-7351.

  • [108] ORAL EA, SIMHA V, RUIZ E, ANDEWELT A, PREMKUMAR A, SNELL P, WAGNER AJ, DEPAOLI AM, REITMAN ML, TAYLOR SI, GORDEN P, GARG A. Leptin-replacement therapy for lipodystrophy. N Engl J Med 2002; 346: 570-578.

  • [109] ORAL EA, RUIZ E, ANDEWELT A, SEBRING N, WAGNER AJ, DE PAOLI AM, GORDEN P. Effect of leptin replacement on pituitary hormone regulation in patients with severe lipodystrophy. J Clin Endocrinol Metab 2002; 87: 3110-3117. [Crossref]

  • [110] OŚWIĘCIMSKA J, ZIORA K, DYDUCH A. Lipodystrofia nabyta i wrodzona. Endokrynologia, Otyłość i Zaburzenia Przemiany Materii 2006; 2(1): 22-29.

  • [111] PAYNE VA, GRIMSEY N, TUTHILL A, VIRTUE S, GRAY SL, DALLA NORA E, SEMPLE RK, O'RAHILLY S, ROCHFORD JJ. The human lipodystrophy gene BSCL2/seipin may be essential for normal adipocyte differentiation. Diabetes 2008; 57(8): 2055-2060. [Crossref]

  • [112] PELLECANI A, CHIN M T, WIESEL P, IBANEZ M, PATEL A, YET S-F, HSIEH C-M, PAULAUSKIS JD, REEVES R, LEE M-E, PERRELLA MA. Induction of high mobility group- I(Y) protein by endotoxin and interleukin-1ß in vascular smooth muscle cells. J Biol Chem 1999; 274: 1525-1532. [Crossref]

  • [113] RABSON SM, MENDENHALL EN. Familial hypertrophy of pineal body, hyperplasia of adrenal cortex and diabetes mellitus; report of 3 cases. Am J Clin Pathol 1956; 26: 283-290.

  • [114] Rabson-Mendenhall syndrome. 262190: Pineal hyperplasia, insulin-resistant diabetes mellitus, and somatic abnormalities. Online Mendelian Inheritance in Man (OMIM). Johns Hopkins University. Creation date - Victor A. McKusick: 6/4/1986. http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi? id=262190.

  • [115] ROMUALDI D, GUIDO M, CIAMPELLI M, GIULIANI M, LEONI F, PERRI C, LANZONE A. Selective effects of pioglitazone on insulin and androgen abnormalities in normo- and hyperinsulinaemic obese patients with polycystic ovary syndrome. Hum Reprod 2003; 18: 1210-1218. [Crossref]

  • [116] ROSE DP, KOMNINOU D, STEPHENSON GD. Obesity, adipocytokines, and insulin resistance in breast cancer. Obes Rev 2004; 5(3): 153-165. [Crossref]

  • [117] ROSENSTEIN ED, ADVANI S, REITZ RE, KRAMER N. The prevalence of insulin receptor antibodies in patients with systemic lupus erythematosus and related conditions. J Clin Rheumatol 2001; 7: 371-373. [Crossref]

  • [118] ROTH SI, SCHEDEWIE HK, HERZBERG VK, OLEFSKY J, ELDERS MJ, RUBENSTEIN A. Cutaneous manifestations of leprechaunism. Arch Dermatol 1981; 117: 531-535. [Crossref]

  • [119] RUBIN CM, HOUCK CM, DENINIGER PL, FRIEDMANN T, SCHMID CW. Partial nucleotide sequence of the 300-nucleotide interspersed repeated human DNA sequences. Nature 1980; 284: 372-374. [Crossref]

  • [120] RUDDON RW, BEDOWS E. Assisted protein folding. J Biol Chem 1997; 272: 3125-3128. [Crossref]

  • [121] RUDMAN D, FELLER AG, NAGRAJ HS, et al. Effects of human growth hormone in men over 60 years old. N Engl J Med 1990; 323: 1-6.

  • [122] SAITOH T, YANAGITA T, SHIRAISHI S, YOKOO H, KOBAYASHI H, MINAMI S-I, ONITSUKA T, WADA A. Down-regulation of cell surface insulin receptor and insulin receptor substrate-1 phosphorylation by inhibitor of 90-kDa Heat-Shock Protein family: endoplasmic reticulum retention of monomeric insulin receptor precursor with calnexin in adrenal chromaffin cells. Mol Pharmacol 2002; 62(4): 847-855.

  • [123] SAKATA S, KOBAYASHI M, MIURA K, ATASSI MZ. Molecular recognition of human insulin receptor by autoantibodies in a human serum. Immunol Invest 1988; 17: 237-242. [Crossref]

  • [124] SALMERON J, ASCHERIO A, RIMM E. Dietary fiber, glycemic load, and risk of NIDDM in men. Diabetes Care 1997; 20: 545. [Crossref]

  • [125] SAWKA-VERHELLE D, TARTARE-DECKERT S, WHITE MF, VAN OBBERGHEN E. Insulin receptor substrate-2 binds to the insulin receptor through its phosphotyrosine-binding domain and through a newly identified domain comprising amino acid J Biol Chem 1996; 271: 5980-5983.

  • [126] SAVKUR RS, PHILIPS AV, COOPER TA. Abberant regulation of insulin receptor alternative splicing is associated with insulin resistance in myotonic dystrophy. Nat Genet 2001; 29: 40-47. [Crossref]

  • [127] SCHLESSINGER J. Ligand-induced, receptor-mediated dimerization and activation of EGF receptor. Cell 2002; 110: 669-672. [Crossref]

  • [128] SCIACCA L, COSTANTINO A, PANDINI G, et al. Insulin receptor activation by IGF-II inbreast cancer: evidence for a new autocrine/paracrine mechanism. Oncogene 1999; 18: 2471-2479. [Crossref]

  • [129] SEELY BL, REICHART DR, TAKATA Y, YIP CC, OLEFSKY JM. A functional assessment of insulin/insulin-like growth factor-I hybrid receptors. Endocrinology 1995; 136: 1635-1641.

  • [130] SEINO S, BELL GI. Alternative splicing of human insulin receptor messenger RNA. Biochem Biophys Res Commun 1989; 159: 312-316. [Crossref]

  • [131] SEINO S, SEINO M, NISHI S, BELL GI. Structure of the human insulin receptor gene and of its promoter. Proc Natl Acad Sci USA 1989; 86: 114-118. [Crossref]

  • [132] SELL SM, REESE D, OSSOWSKI VM. Insulin-inducible changes in insulin receptor mRNA splice variants. J Biol Chem 1994; 269: 30769-30772.

  • [133] SEN S, TALUKDAR I, WEBSTER NJG. SRp20 and CUG-BP1 modulate insulin receptor exon 11 alternative splicing. Moll Cell Biol 2009; 29(3): 871-880.

  • [134] SESTI G, MARINI MA, MONTEMURRO A, et al. Evidence that two naturally occuring human insulin receptor alpha-subunit variants are immunologically distinct. Diabetes 1992; 41: 6-11. [Crossref]

  • [135] SESTI G, TULLIO AN, MARINI MA, et al. Role of the exon 11 of the insulin receptor gene on insulin binding identified by antipeptide antibodies. Moll Cell Endocrinol 1994; 101: 121-127.

  • [136] SESTI G, TULLIO AN, D’ALFONSO R, et al. Tissue-specific expression of two alternatively spliced isoforms of the human insulin receptor protein. Acta Diabetologica 1994; 31: 59-65. [Crossref]

  • [137] SESTI G, FEDERICI M, LAURO D, SBRACCIA P, LAURO R. Molecular mechanism of insulin resistance in type 2 diabetes mellitus: role of the insulin receptor variant forms. Diabetes Metab Res Rev 2001; 17: 363-373. [Crossref]

  • [138] SIMHA V, GARG A. Inherited lipodystrophies and hypertriglyceridemia. Curr Opin Lipidol 2009; 20(4): 300-308. [Crossref]

  • [139] SINGER-SAM J, KEITH DH, TANI K, SIMMER RL, SHIVELY L, LINDSAY S, YOSHIDA A, RIGGS AD. Sequence of the promoter region of the gene for human X-linked 3-phosphoglycerate kinase. Gene 1984; 32: 409-417. [Crossref]

  • [140] SINGH NN, SINGH RN, ANDROPHY EJ. Modulating role of RNA structure in alternative splicing of a critical exon in the spinal muscular atrophy genes. Nucleic Acids Res 2007; 35(2):371-389.

  • [141] SKUPIEŃ J, MAŁECKI MT. Rozbudowywanie podziału cukrzycy - nowe podtypy i możliwości lecznicze. Diabetologia Praktyczna 2007; 8(1): 1-12.

  • [142] SOLNICK D. Alternative splicing caused by RNA secondary structure. Cell 1985; 43: 667-676. [Crossref]

  • [143] SOLNICK D, LEE SI. Amount of RNA secondary structure required to induce an alternative splice. Moll Cell Biol 1987; 7: 3194-3198.

  • [144] SOOS MA, FIELD CE, SIDDLE K. Purified hybrid insulin/insulin-like growth factor-I receptors bind insulin-line growth factor-I but not insulin, with high affinity. Biochem J 1993; 290: 419-426.

  • [145] STANDAERT ML, SCHIMMEL SD, POLLET RJ. The development of insulin receptors and responses in the differentiating non-fusing muscle cell line BC3H-1. J Biol Chem 1984; 259: 2337-2345.

  • [146] STEFANOVSKY VY, PELLETIER G, HANNAN R, GAGNON-KUGLER T, ROTHBLUM LI, MOSS T. An immediate reponse of ribosomal transcription to growth factor stimulation in mammals is mediated by ERK phosphorylation of UBF. Mol Cell 2001; 8: 1063-1073. [Crossref]

  • [147] SZYMANSKI KM, BINNS D, BARTZ R, GRISHIN NV, LI WP, AGARWAL AK, GARG A, ANDERSON RG, GOODMAN JM. The lipodystrophy protein seipin is found at endoplasmic reticulum lipid droplet junctions and is important for droplet morphology. Proc Natl Acad Sci USA 2007; 104(52): 20890-20895. [Crossref]

  • [148] TALUKDAR I, SEN S, WEBSTER N. SRp20, hnRNP A1 and F regulate alternative splicing of insulin receptor via binding to the intronic regulatory elements. FASEB J 2008; 22: 601.1.

  • [149] TANIGUCHI CM, EMANUELLI B, KHAN CR. Critical nodes in signalling pathways: insights into insulin action. Nat Rev Mol Cell Biol 2006; 7: 85-96. [Crossref]

  • [150] TEWARI DS, COOK DM, TAUB R. Characterization of the promoter region and 3’ end of the human insulin receptor gene. J Biol Chem 1989; 264(27): 16238-16245.

  • [151] THIEL CT, KNEBEL B, KNERR I, STICHT H, MÜLLER-WIELAND D, ZENKER M, REIS A, DÖRR H-G, RAUCH A. Two novel mutations in the insulin binding subunit of the insulin receptor gene without insulin binding impairment in a patient with Rabson-Mendenhall syndrome. Mol Genet Metab 2008; 94: 356-362. [Crossref]

  • [152] TUTHILL A, SEMPLE RK, DAY R, SOOS M, SWEENEY E, SEYMOUR PJ, DIDI M, O’RAHILLY S. Functional characterization of a novel insulin receptor mutation contributing to Rabson-Mendenhall syndrome. Clin Endocrinol 2007; 66: 21-26.

  • [153] ULLRICH A, BELL JR, CHEN EY, HERRERA R, PETRUZZELLI LM, DULL TJ, GRAY A, COUSSENS L, LIAO YC, TSUBOKAWA M, et al. Human insulin receptor and its relationship to the tyrosine kinase family of oncogenes. Nature 1985; 313: 756-761. [Crossref]

  • [154] VOGT B, CARRASCOSA JM, ERMEL B, ULLRICH A, HARING HU. The two isotypes of the human insulin receptor (HIR-A and HIR-B) follow different internalization kinetics. Biochem Biophys Res Commun 1991; 177: 1013-1018. [Crossref]

  • [155] VOJTEK AB, DER CJ. Increasing complexity of the Ras signaling pathway. J Biol Chem 1998; 273: 19925-19928. [Crossref]

  • [156] VELAZQUEZ EM, MENDOZA S, HAMER T, SOSA F, GLUECK CJ. Metformin therapy in polycystic ovary syndrome reduces hyperinsulinemia, insulin resistance, hyperandrogenemia, and systolic blood pressure, while facilitating normal menses and pregnancy. Metabolism 1994; 43: 647-654. [Crossref]

  • [157] WALDHAUSER F, WEISSENBACHER G, FRISCH H, POLLAK A. Pulsatile secretion of gonadotropins in early infancy. Eur J Pediatr 1981; 137: 71-74. [Crossref]

  • [158] WEBSTER NJG, EVANS L-G, CAPLES M, ERKER L, CHEW SL. Assembly of splicing complexes on exon 11 of the human insulin receptor gene does not correlate with splicing efficiency in-vitro. BMC Mol Biol 2004; 5(7). [Crossref]

  • [159] WHITE MF. The insulin signaling system and the IRS proteins. Diabetologia 1997; 40: Suppl. 2-17. [Crossref]

  • [160] WHITE MF, KAHN CR. The insulin signaling system. J Biol Chem 1994; 269: 1-4.

  • [161] YAMAGUCHI Y, FLIER JS, YOKOTA A, BENECKE H, BACKER JM, MOLLER DE. Functional properties of two naturally occurring isoforms of the human insulin receptor in Chinese hamster ovary cells. Endocrinology 1991; 129: 2058-2066. [Crossref]

  • [162] YAMAGUCHI Y, FLIER JS, BENECKE H, RANSIL BJ, MOLLER DE. Ligand-binding properties of the two isoforms of the human insulin receptor. Endocrinology 1993; 132: 1132-1138.

  • [163] ZYROMSKI NJ, MATHUR A, PITT HA, WADE TE, WANG S, NAKSHATRI P, SWARTZBASILE DA, NAKSHATRI H. Obesity potentiates the growth and dissemination of pancreatic cancer. Surgery 2009; 146(2): 258-263 [Crossref]

About the article

Published Online: 2014-10-15

Published in Print: 2010-02-01

Citation Information: Advances in Cell Biology, ISSN (Online) 2080-2218, DOI: https://doi.org/10.2478/v10052-010-0004-8. Export Citation

© by Aleksandra Rojek. This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License. (CC BY-NC-ND 3.0)

Comments (0)

Please log in or register to comment.
Log in